Design and tumor targeting of anthracyclines able to overcome multidrug resistance: A double-advantage approach

This publication has 24 references indexed in Scilit:

• Dissection of the free energy of anthracycline antibiotic binding to DNA: electrostatic contributions
  Journal of the American Chemical Society, 1993
• Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
  Science, 1992
• P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma
  New England Journal of Medicine, 1991
• Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.
  Journal of Clinical Oncology, 1990
• 9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance
  European Journal of Cancer and Clinical Oncology, 1990
• N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo
  British Journal of Cancer, 1989
• Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A
  Biochemical Pharmacology, 1989
• THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
  Annual Review of Biochemistry, 1989
• Synthesis of 2′-Iodo Analogues of β-Rhodomycins1
  Journal of Carbohydrate Chemistry, 1989
• Oxyhalogenation of glycals for the synthesis of anti-tumor-active 2′-halo daunorubicin analogs
  Carbohydrate Research, 1985